Evidence for a M1 muscarinic receptor on the endothelium of human pulmonary veins
- 1 May 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 130 (1), 73-78
- https://doi.org/10.1038/sj.bjp.0703301
Abstract
1. To characterize the muscarinic receptors on human pulmonary veins associated with the acetylcholine (ACh)-induced relaxation, isolated venous and arterial preparations were pre-contracted with noradrenaline (10 microM) and were subsequently challenged with ACh in the absence or presence of selective muscarinic antagonists. 2. ACh relaxed venous preparations derived from human lung with a pD(2) value of 5.82+/-0.09 (n=16). In venous preparations where the endothelium had been removed, the ACh relaxations were abolished (n=4). ACh relaxed arterial preparations with a pD(2) value of 7. 06+/-0.14 (n=5). 3. Atropine (1 microM), the non selective antagonist for muscarinic receptors, inhibited ACh-induced relaxations in human pulmonary veins. The affinity value (pK(B) value) for atropine was: 8.64+/-0.10 (n=5). The selective muscarinic antagonists (darifenacin (M(3)), himbacine (M(2),M(4)), methoctramine (M(2)) and pFHHSiD (M(1),M(3))) also inhibited ACh-induced relaxations in venous preparations. The pK(B) values obtained for these antagonists were not those predicted for the involvement of M(2 - 5) receptors in the ACh-induced relaxation in human pulmonary veins. 4. The pK(B) value for darifenacin (1 microM) was significantly greater in human pulmonary arterial (8.63+/-0.14) than in venous (7.41+/-0.20) preparations derived from three lung samples. 5. In human pulmonary veins, the pK(B) values for pirenzepine (0.5 and 1 microM), a selective antagonist for M(1) receptors, were: 7.89+/-0.24 (n=7) and 8.18+/-0.22 (n=5), respectively. In the venous preparations, the pK(B) values derived from the functional studies with all the different muscarinic antagonists used were correlated (r=0.89; P=0.04; slope=0.78) with the affinity values (pK(i) values) previously published for human cloned m1 receptors in CHO cells. 6. These results suggest that the relaxations induced by ACh are due to the activation of M(1) receptors on endothelial cells in isolated human pulmonary veins.Keywords
This publication has 60 references indexed in Scilit:
- Interaction of neuromuscular blocking drugs with recombinant human m1–m5 muscarinic receptors expressed in Chinese hamster ovary cellsBritish Journal of Pharmacology, 1998
- Cholinesterase activity in human pulmonary arteries and veinsBritish Journal of Pharmacology, 1997
- Differential responses of ovine intrapulmonary arteries and veins to acetylcholineRespiration Physiology, 1996
- In Vivo Characterization of Muscarinic Receptor Subtypes That Mediate Vasodilatation in Patients With Essential HypertensionHypertension, 1995
- Cholinergic Receptor-Mediated Responses in the Arteriolar and Venous Vascular Beds of the Human ForearmBlood Pressure, 1995
- A toxin from the green mamba Dendroaspis angusticeps: Amino acid sequence and selectivity for muscarinic m4 receptorsFEBS Letters, 1994
- Muscarinic Receptor Subtypes Mediating Vasodilation and Vasoconstriction in Isolated, Perfused Simian Coronary ArteriesJournal of Cardiovascular Pharmacology, 1993
- Distribution of cholinesterase in canine venous system.The Japanese Journal of Pharmacology, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980